Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-008860

Chief Scientific Officer sold 383 shares at $12.68 ($4,857)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Monahan Joseph Chief Scientific Officer 2022-02-09 Sale −383 $12.68 $4,857 87,301 D: show line 1 in the form
Open-market sales · 383 sh · avg $12.68 · $4,857
Loading xslF345X03/doc4.xml…